Dynavax Technologies
Presence
Dynavax Technologies is one of the...
Dynavax Technologies is a company listed under the stock ticker DVAX (US).
Executives
View the org chart displaying its 28 main executives
Most searched biographies at Dynavax Technologies
- Ryan Spencer, Chief Executive Officer and Director
- Daniel Kisner, Director
- Brent MacGregor, Director
Create your alert
to follow the executive moves at Dynavax Technologies.
Biotechnology
Dynavax Technologies has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
- Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Dynavax Technologies
- RSS News Feeds | Dynavax Technologies Corporation
- Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October | Dynavax Technologies Corporation
- Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate | Dynavax Technologies Corporation
- Dynavax Announces Appointment of New Board Member and Planned Retirement of Chief Financial Officer | Dynavax Technologies Corporation
- Press Releases | Dynavax Technologies Corporation
- Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine | Dynavax Technologies Corporation
- Dynavax to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference | Dynavax Technologies Corporation
- Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Response | Dynavax Technologies Corporation
- Dynavax Announces Second Quarter 2020 Financial Results | Dynavax Technologies Corporation
- TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales | Dynavax Technologies Corporation
- View more press releases Close
Social media about Dynavax Technologies
- Dynavax Technologies on Wikipedia, Google News & Yahoo Finance
- Dynavax Technologies on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Ryan Spencer 
Call Dynavax Technologies at +1 510...
